Diabetes mellitus Posts on Medivizor
Navigation Menu

Diabetes mellitus Posts on Medivizor

Safety of empagliflozin in type 2 diabetes

Posted by on Oct 13, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the safety of empagliflozin (Jardiance) in patients with type 2 diabetes (T2D). It was determined that empagliflozin is a safe drug, but may increase the risk of genital infections. Some background Empagliflozin is an SGLT2 inhibitor. SGLT2 is a protein in the kidneys that is important in controlling blood...

Read More

Flaxseed oil omega-3 fatty acids: a new treatment for diabetic foot ulcer?

Posted by on Oct 12, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the effects of supplementation with flaxseed oil omega-3 fatty acids on diabetic foot ulcers. They found that treatment with omega-3 fatty acids improved diabetic would healing over a 12-week period. Some background Diabetic foot ulcer (DFU) is a serious complication of diabetes, causing a debilitating...

Read More

SGLT2 inhibitors and infections

Posted by on Oct 6, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the effects of SGLT2 inhibitors on urinary tract infections (UTIs) and genital infections in patients with type 2 diabetes (T2D). It was determined that SGLT2 inhibitors increase the risk of genital infections, but not UTIs. Some background SGLT2 is a protein in the kidneys that is important in controlling...

Read More

Glyburide: a safe and effective medication for the treatment of gestational diabetes?

Posted by on Oct 6, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated if glyburide (Glynase) was safer and more effective than insulin in patients with gestational diabetes. They found that glyburide was associated with an increased risk of neonatal hypoglycemia (low blood sugar) but was well tolerated overall.  Some background Gestational diabetes mellitus (GDM)...

Read More

What anti-diabetic drugs are safe and effective in treating gestational diabetes?

Posted by on Oct 6, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the safety and effectiveness of different drugs used to treat gestational diabetes. They found that metformin (Glucophage) is associated with fewer pregnancy complications than glyburide (Glynase), however it is less effective at managing blood sugar levels.  Some background Gestational diabetes...

Read More

Can lifestyle interventions improve glycemic control in people with advanced type 2 diabetes?

Posted by on Oct 6, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study examined whether lifestyle interventions could improve control of blood glucose levels (glycemic control) in people with advanced type 2 diabetes (T2D). They determined that certain lifestyle interventions resulted in a significant decrease in HbA1c levels (a measure of glycemic control).  Some background T2D is...

Read More

Can lifestyle intervention improve blood sugar control in patients with type 2 diabetes?

Posted by on Oct 6, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated whether lifestyle interventions improved glycemic (blood sugar) control in patients with type 2 diabetes. They found that lifestyle intervention slightly improved glycemic control and reduced the needed dose of diabetes medication in these patients.  Some background Managing type 2 diabetes initially...

Read More

Is the efficacy of dulaglutide impacted by gender or disease features in type 2 diabetes?

Posted by on Sep 30, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated if dulaglutide is a safe and effective medication for the treatments of type 2 diabetes. They found that dulaglutide effectively improved blood glucose control regardless of gender or disease duration.  Some background Management of blood glucose (sugar) levels is important in type 2 diabetes. To do this,...

Read More

Do dipeptidyl peptidase-4 (DPP-4) inhibitors increase the risk of joint pain?

Posted by on Sep 21, 2017 in Diabetes mellitus | 0 comments

In a nutshell  This study compared data from clinical trials investigating if dipeptidyl peptidase-4 (DPP-4) inhibitors are associated with a greater risk of arthralgia (joint pain) in type 2 diabetes patients. They found there was slight increased risk for developing arthralgia in patients taking DPP-4 inhibitors. Some background Managing...

Read More